Melissa Gilmore from DLA Piper shares the FDA’s plans for terminating COVID-10 EUAs in simple terms. She describes the path for those intending to continue producing the medical devices. Companies intending to cease production also have a path and timeline to guide their plans.

Click here to read about the FDA’s plan.